Hypertriglyceridemia
📧 Sign up to get email alerts when something new happens for Hypertriglyceridemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-08-28FDA Approved: FENOFIBRATE — Original Application (Solco Healthcare US, LLC)
FDA approved the original application for fenofibrate (generic) from Solco Healthcare US, LLC, authorizing its use for certain lipid disorde…
-
FDA approval · 2018-08-28FDA Approved: GEMFIBROZIL — Original Application (Zydus Lifesciences Limited)
FDA approved the original ANDA for Gemfibrozil from Zydus Lifesciences Limited, making a generic fibrate available in the United States.
-
FDA approval · 2018-08-17FDA Approved: FENOFIBRATE — Original Application (Leading Pharma, LLC)
FDA approved Leading Pharma, LLC's original Abbreviated New Drug Application for fenofibrate, enabling marketing of a generic fenofibrate pr…
-
FDA approval · 2018-07-20FDA Approved: FENOFIBRATE — Original Application (Ajanta Pharma USA Inc.)
The FDA approved Ajanta Pharma USA Inc.'s generic fenofibrate (FENOFIBRATE) under an Original Abbreviated New Drug Application.
-
FDA approval · 2018-06-26FDA Approved: FENOFIBRATE — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Fenofibrate's original application from Torrent Pharmaceuticals Limited under ANDA210782, making a generic option available for…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-05-18FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for fenofibrate submitted by Lupin Pharmaceuticals, Inc. The notice indicates an updated approval fo…
-
FDA approval · 2018-05-18FDA Approved: FENOFIBRATE — Supplemental Application (Cipla USA Inc.,)
FDA approved a supplemental application for fenofibrate filed by Cipla USA Inc. under ANDA207378.
-
FDA approval · 2018-05-18FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for fenofibrate from Amneal Pharmaceuticals NY LLC, approving a generic fenofibrate product.
-
FDA approval · 2018-05-18FDA Approved: LIPOFEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Lipofen (fenofibrate) filed by ANI Pharmaceuticals, Inc.
-
FDA approval · 2018-05-18FDA Approved: FENOFIBRATE — Supplemental Application (Bostal LLC)
FDA approved a supplemental application for Fenofibrate submitted by Bostal LLC under ANDA 207805. The approval confirms the continued appro…
-
FDA approval · 2018-04-30FDA Approved: FENOFIBRATE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' generic fenofibrate under an Original Application (ANDA 209504).
-
FDA approval · 2018-04-25FDA Approved: LOPID — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for Lopid (gemfibrozil) submitted by Parke-Davis Div of Pfizer Inc.
-
FDA approval · 2018-04-20FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for fenofibrate from Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2018-03-19FDA Approved: FENOFIBRATE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC's fenofibrate generic under an original application (ANDA). This represents the approval of a fen…
-
FDA approval · 2018-02-09FDA Approved: FENOFIBRATE — Original Application (AvKARE)
FDA approved AvKARE's generic fenofibrate under an Original Application (ANDA 209951).
-
FDA approval · 2018-02-01FDA Approved: NIACIN — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original ANDA for NIACIN, a generic niacin product intended to treat dyslipidemia and related lipid …
-
FDA approval · 2017-12-19FDA Approved: FENOFIBRATE — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' original application for fenofibrate, authorizing the marketing of a generic fenofibrate product.
-
FDA approval · 2017-11-16FDA Approved: FENOFIBRATE — Original Application (Bostal LLC)
FDA approved fenofibrate from Bostal LLC through an original application (ANDA 207805).
-
FDA approval · 2017-10-02FDA Approved: GEMFIBROZIL — Supplemental Application (Exelan Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Gemfibrozil submitted by Exelan Pharmaceuticals, Inc.
-
FDA approval · 2017-09-19FDA Approved: OMEGA-3-ACID ETHYL ESTERS — Original Application (Strides Pharma Science Limited)
FDA approved the original application for Omega-3-acid ethyl esters from Strides Pharma Science Limited, a generic prescription therapy used…
-
FDA approval · 2017-09-11FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for fenofibrate from Lupin Pharmaceuticals, Inc., signaling an approved modification to the existing…
-
FDA approval · 2017-09-11FDA Approved: GEMFIBROZIL — Supplemental Application (Cadila Pharmaceuticals Limited)
The FDA approved a supplemental application for Gemfibrozil filed by Cadila Pharmaceuticals Limited.
-
FDA approval · 2017-09-07FDA Approved: FENOFIBRATE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries, Inc.'s original ANDA for fenofibrate (generic fenofibrate).
-
FDA approval · 2017-05-12FDA Approved: FENOFIBRIC ACID — Original Application (Alembic Pharmaceuticals Limited)
FDA approved an original application for a generic fenofibric acid product manufactured by Alembic Pharmaceuticals Limited.
-
FDA approval · 2017-04-07FDA Approved: FENOFIBRATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's original application for Fenofibrate (generic), a lipid-lowering drug for hyperlipidemia, hypertriglyceridemia, …